Markets & regulatory news

Scottish life sciences sector grows

Scotland's pharma services sector grows with Govt support

By Gareth Macdonald

Scotland’s emergence as a biopharma hub – as evidenced by announcements by SAFC and Quintiles last week – is due to Government support, electronic health records and speedy trial approvals says Scottish Enterprise.

PPMA calls for action Govt DRA

Pakistan drugmakers need Govt action on DRA says PPMA

By Gareth Macdonald

Drugmakers in Pakistan are suffering and parliament needs to implement on the proposed Drug Regulatory Authority (DRA) according to the Pakistan Pharmaceutical Manufacturers Association (PPMA).

Fercy receives FDA warning letter

Fercy receives FDA warning letter

Fercy Personal Care Products received an FDA warning letter after quality staff handed inspectors just two pages from a notebook as ingredient records.

Recipharm given the go-ahead in France

Recipharm gets OK in France

Swedish CDMO Recipharm has been cleared by French regulators to fill biotech drug products at its site in Tours.

Health Canada's new risk-based inspection classification

UPDATE

Health Canada launches risk-based inspection classification system

By Natalie Morrison

Since the publication of this article, in-PharmaTechnologist.com has been in touch with Health Canada to find out that the "updates" to the guidance document were actually to the font, not to the regulations. Health Canada launched no disclaimer...

FDA reviews cancer drugs faster then EMA

US OKs cancer drugs faster than Europe, Tufts

US regulators approve cancer drugs faster than other medications and much faster than their European counterparts according to a new survey by the Tufts Center for the Study of Drug Development. 

Follow us

Products

View more

Webinars